Search Results - "Chevalier, Annick"

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial by Gladieff, Laurence, Martínez-García, Jerónimo, Villacampa, Guillermo, Takekuma, Munetaka, De Giorgi, Ugo, Lindemann, Kristina, Woelber, Linn, Colombo, Nicoletta, Duska, Linda, Leary, Alexandra, Godoy-Ortiz, Ana, Angelergues, Antoine, Rubio, Maria Jesús, Fariñas-Madrid, Lorena, Lorusso, Domenica, Ray-Coquard, Isabelle, Manso, Luis, Joly, Florence, Alarcón, Jesús, Follana, Philippe, Romero, Ignacio, Lebreton, Coriolan, Pérez-Fidalgo, J Alejandro, Yunokawa, Mayu, Dahlstrand, Hanna, Abadie-Lacourtoisie, Sophie, Anzizar, Nerea, Aoki, Daiseuke, Barretina-Ginesta, Maria-Pilar, Battista, Marco, Bentzen, Anne Gry, Berton, Dominique, Bjørge, Line, Bjurberg, Maria, Bologna, Alessandra, Casanova, Claudia, Chekerov, Radoslav, Chevalier, Annick, Cueva, Juan Fernando, Czogalla, Bastian, Delanoy, Nicolas, Denschlag, Dominik, Derke, Oscar, Eichbaum, Michael, Enomoto, Takayuki, Esteban, Carmen, Fabbro, Michel, Fehm, Tanja, Ferrero, Annamaria, Fleisch, Markus, Floquet, Anne, Frassoldati, Antonio, Gaba, Lydia, Gadducci, Angiolo, García, Yolanda, Geuna, Elena, Hanker, Lars, Hardy-Bessard, Anne-Claire, Harter, Philipp, Hasegawa, Kosei, Hellman, Kristina, Herrero, Ana, Hilpert, Felix, Katsaros, Dionyssios, Koegel, Matthias, Koliadi, Anthoula, Kurtz, Jean-Emmanuel, Lampe, Bjoern, Lissoni, Andrea Alberto, Lortholary, Alain, Mangili, Giorgia, Mansi, Laura, Marmé, Frederik, Mathews, Cara, Mina, William, Nagao, Shoji, Nishino, Koji, Nishio, Hiroshi, Nishio, Shin, Oaknin, Ana, Onstad, Michaela, Pardo, Beatriz, Pisano, Carmela, Poveda, Andrés, Radosa, Julia, Randall, Leslie M., Ray-Coquard, Isabelle, Richardson, Debra, Romero, Ignacio, Ronzino, Graziana, Rubio, Maria Jesús, Selle, Frederic, Takekuma, Munetaka, Takeshima, Nobuhiro, Tewari, Krishnansu, Todo, Yukiharu, Wimberger, Pauline, Woelber, Linn, You, Benoît, Yunokawa, Mayu

“…The GOG240 trial established bevacizumab with chemotherapy as standard first-line therapy for metastatic or recurrent cervical cancer. In the BEATcc trial…”
Get full text

Immune tumor microenvironnement (iTME) post-neoadjuvant chemotherapy, beyond PD-L1: Novel immune targets in ovarian cancer, data from the CHIVA trial, a GINECO/GINEGEPS study by Blanc-Durand, Felix, Yaniz-Galende, Elisa, Genestie, Catherine, Gauthier De Saint Basile, Hortense, Chardin, Laure, De Rauglaudre, Gaetan, Raban, Nadia, Chevalier, Annick, Ferron, Gwenael, Kaminsky, Marie-Christine, Ray-Coquard, Isabelle Laure, Hamizi, Salima, Combe, Pierre, Abadie Lacourtoisie, Sophie, Joly, Florence, Meunier, Jérome, Floquet, Anne, Alexandre, Jérôme, Le Formal, Audrey, Leary, Alexandra

“…5554 Background: Antibodies targeting PDL1 or PD1 have been disappointing so far in the treatment of ovarian cancer (OC). A greater understanding of the…”
Get full text

Victoria: A multicentric, randomized, open-label, phase I/II of mTOR inhibitor (VISTUSERTIB) combined with anastrozole in patients with hormone receptor-positive advanced/metastatic endometrial cancer—A CLIPP program INCA in collaboration with GINECO group by Heudel, Pierre-Etienne, Frenel, Jean-Sebastien, Dalban, Cécile, Bazan, Fernando, Joly, Florence, Arnaud, Antoine, Abdeddaim, Cyril, Chevalier, Annick, Augereau, Paule, Pautier, Patricia, Chakiba, Camille, You, Benoit, Lancry Lecomte, Laurence, Garin, Gwenaelle, MArcel, Virginie, Diaz, Jean-Jacques, Treilleux, Isabelle, Pérol, David, Fabbro, Michel, Ray-Coquard, Isabelle Laure

“…Abstract only 5507 Background: Endometrial carcinoma is generally hormone dependent and aromatase inhibitors are used in routine practice before or after 1 st…”
Get full text

Multicentre randomized phase II trial of olaparib as maintenance therapy in platinum-sensitive advanced endometrial carcinoma: The GINECO-UTOLA study by Joly, Florence, Brachet, Pierre Emmanuel, Abadie Lacourtoisie, Sophie, Asselain, Bernard, Floquet, Anne, Collard, Olivier, Rodrigues, Manuel, Leroy, Karen, Jeanne, Corinne, Leary, Alexandra, Betrian, Sarah, You, Benoit, Fernandez Diez, Yolanda, Hardy-Bessard, Anne-Claire, Chevalier, Annick, Kalbacher, Elsa, Cornila, Corina, Foa, Cyril, Follana, Philippe, Alexandre, Jerome

“…Abstract only TPS6109 Background: Advanced endometrial cancer (EC) patients relapse despite treatment with combination chemotherapy and have a short…”
Get full text

Impact of adding nintedanib to neoadjuvant chemotherapy (NACT) for advanced epithelial ovarian cancer (EOC) patients: The CHIVA double-blind randomized phase II GINECO study by Ferron, Gwenael, De Rauglaudre, Gaetan, Chevalier, Annick, Combe, Pierre, Joly, Florence, Lortholary, Alain, Raban, Nadia, Hamizi, Salima, Malaurie, Emmanuelle, Kaminsky, Marie-Christine, Pautier, Patricia, Meunier, Jérome, Alexandre, Jérôme, Berton-Rigaud, Dominique, Floquet, Anne, Venat-Bouvet, Laurence, Favier, Laure, Dohollou, Nadine, Dubot, Coraline, Ray-Coquard, Isabelle Laure

“…Abstract only 5512 Background: Nintedanib, an oral inhibitor of VEGF-FGF-PDGF receptors, has been shown to prolong progression-free survival (PFS) when added…”
Get full text

Modeled CA-125 kinetics during neoadjuvant chemotherapy for predicting the likelihood of optimal interval debulking surgery in ovarian cancer patients: Data from CHIVA trial (a GINECO study) by Robelin, Patrick, Tod, Michel, Colomban, Olivier, Louvet, Christophe, Lotz, Jean-Pierre, Abadie Lacourtoisie, Sophie, Fabbro, Michel, Desauw, Christophe, Bonichon, Nathalie, Kurtz, Jean Emmanuel, Follana, Philippe, Leheurteur, Marianne, Del Piano, Francesco, Alliot, Carol René, De Rauglaudre, Gaetan, Ray-Coquard, Isabelle Laure, Combe, Pierre, Chevalier, Annick, Joly, Florence, You, Benoit

“…Abstract only 5546 Background: A pre-operative predictive biomarker of CC0 interval debulking surgery (IDS) likelihood would be helpful. The modeled CA125…”
Get full text

A New Paradigm in Managing Advanced Ovarian Cancer: Differentiating Patients Requiring Neoadjuvant Treatment from Primary Cytoreduction by Kraus, Francois, El Hajj, Houssein, Le Deley, Marie-Cécile, Aissaoui, Othman, Gachon, Bertrand, Chevalier, Annick, Abdeddaim, Cyril, Lemaire, Anne-Sophie, Ben Haj Amor, Mariem, Sylla, Dienabou, Leblanc, Eric, Narducci, Fabrice, Hudry, Delphine

“…Our study aims to evaluate the comparability of primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) patients. This single-center retrospective…”
Get full text

CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial by You, Benoit, Robelin, Patrick, Tod, Michel, Louvet, Christophe, Lotz, Jean-Pierre, Abadie-Lacourtoisie, Sophie, Fabbro, Michel, Desauw, Christophe, Bonichon-Lamichhane, Nathalie, Kurtz, Jean-Emmanuel, Follana, Philippe, Leheurteur, Marianne, Piano, Francesco Del, Ferron, Gwénael, De Rauglaudre, Gaëtan, Ray-Coquard, Isabelle, Combe, Pierre, Chevalier-Place, Annick, Joly, Florence, Leary, Alexandra, Pujade-Lauraine, Eric, Freyer, Gilles, Colomban, Olivier

“…In patients with ovarian cancer receiving neoadjuvant chemotherapy, the first-line treatment success will depend on both the tumor-primary chemosensitivity and…”
Get full text

A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer by Blanc-Durand, Félix, Yaniz-Galende, Elisa, Llop-Guevara, Alba, Genestie, Catherine, Serra, Violeta, Herencia-Ropero, Andrea, Klein, Christophe, Berton, Dominique, Lortholary, Alain, Dohollou, Nadine, Desauw, Christophe, Fabbro, Michel, Malaurie, Emmanuelle, Bonichon-Lamaichhane, Nathalie, Dubot, Coraline, Kurtz, Jean Emmanuel, de Rauglaudre, Gaëtan, Raban, Nadia, Chevalier-Place, Annick, Ferron, Gwenael, Kaminsky, Marie-Christine, Kramer, Claire, Rouleau, Etienne, Leary, Alexandra

“…Homologous recombination deficiency (HRD), defined as BRCA1/2 mutation (BRCAmut) or high genomic instability, is used to identify ovarian cancer (OC) patients…”
Get full text

Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical Trial by Heudel, Pierre, Frenel, Jean-Sébastien, Dalban, Cécile, Bazan, Fernando, Joly, Florence, Arnaud, Antoine, Abdeddaim, Cyril, Chevalier-Place, Annick, Augereau, Paule, Pautier, Patricia, Chakiba, Camille, You, Benoit, Lancry-Lecomte, Laurence, Garin, Gwenaelle, Marcel, Virginie, Diaz, Jean Jacques, Treilleux, Isabelle, Pérol, David, Fabbro, Michel, Ray-Coquard, Isabelle

“…Endometrial cancer is often hormone-dependent and treated with aromatase inhibitors. The PI3K-AKT-mTOR pathway deregulation observed in endometrial cancer…”
Get more information

Corrigendum to “A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer” by Blanc-Durand, Félix, Yaniz-Galende, Elisa, Llop-Guevara, Alba, Genestie, Catherine, Serra, Violeta, Herencia-Ropero, Andrea, Klein, Christophe, Berton, Dominique, Lortholary, Alain, Dohollou, Nadine, Desauw, Christophe, Fabbro, Michel, Malaurie, Emmanuelle, Bonichon-Lamaichhane, Nathalie, Dubot, Coraline, Kurtz, Jean Emmanuel, de Rauglaudre, Gaëtan, Raban, Nadia, Chevalier-Place, Annick, Ferron, Gwenael, Kaminsky, Marie-Christine, Kramer, Claire, Rouleau, Etienne, Leary, Alexandra

Get full text

Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer by Leman, Raphaël, Muller, Etienne, Legros, Angelina, Goardon, Nicolas, Chentli, Imène, Atkinson, Alexandre, Tranchant, Aurore, Castera, Laurent, Krieger, Sophie, Ricou, Agathe, Boulouard, Flavie, Joly, Florence, Boucly, Romain, Dumont, Aurélie, Basset, Noémie, Coulet, Florence, Chevalier, Louise-Marie, Rouleau, Etienne, Leitner, Katharina, González-Martin, Antonio, Gargiulo, Piera, Lück, Hans-Joachim, Genestie, Catherine, Bogner, Gerhard, Marth, Christian, Petru, Edgar, Reinthaller, Alexander, Schauer, Christian, Sevelda, Paul, D'Hondt, Lionel, Vergote, Ignace, Vuylsteke, Peter, Hietanen, Sakari, Lindahl, Gabriel, Mäenpää, Johanna, Nøttrup, Trine Jakobi, Puistola, Ulla, Abadie-Lacourtoisie, Sophie, Alexandre, Jérôme, Boissier, Emilie, Bourgeois, Hugues, Chevalier-Place, Annick, Combe, Pierre, Costan, Cristina, Dauba, Jérôme, De Cock, Laure, Desauw, Christophe, Despax, Raymond, Dohollou, Nadine, Dubot, Coraline, Fabbro, Michel, Favier, Laure, Floquet, Anne, Follana, Philippe, Tixidre, Claire Garnier, Garnier, Georges, Gladieff, Laurence, Grenier, Julien, Guillemet, Cécile, Hardy-Bessard, Anne-Claire, Joly, Florence, Kalbacher, Elsa, Kaminsky, Marie-Christine, Kurtz, Jean-Emmanuel, Largillier, Rémy, Lefeuvre-Plesse, Claudia, Lesoin, Anne, Levache, Charles-Briac, L'Haridon, Tifenn, Lortholary, Alain, Lotz, Jean-Pierre, Meunier, Jérôme, Mousseau, Mirerille, Mouret-Reynier, Marie-Ange, Pautier, Patricia, Petit, Thierry, Provansal, Magali, Pujade-Lauraine, Eric, Raban, Nadia, Ray-Coquard, Isabelle, Rodrigues, Manuel, Selle, Frédéric, Sverdlin, Robert, Tazi, Youssef, You, Benoît, Aktas, Bahriye, Bauerschlag, Dirk Olaf, Beck, Thomas, Belau, Antje, Bronger, Holger, Buchholz, Stefan, Buderath, Paul, Burges, Alexander, Canzler, Ulrich, de Gregorio, Nikolaus, Denschlag, Dominik, Dieterich, Max, Eichbaum, Michael, El-Balat, Ahmed, Emons, Günter

“…Abstract Purpose: The optimal application of maintenance PARP inhibitor therapy for ovarian cancer requires accessible, robust, and rapid testing of homologous…”
Get full text

Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study) by Robelin, Patrick, Tod, Michel, Colomban, Olivier, Lachuer, Joel, Ray-Coquard, Isabelle, Rauglaudre, Gaëtan De, Joly, Florence, Chevalier-Place, Annick, Combe, Pierre, Lortholary, Alain, Hamizi, Salima, Raban, Nadia, Ferron, Gwénaël, Meunier, Jérôme, Berton-Rigaud, Dominique, Alexandre, Jérôme, Kaminsky, Marie-Christine, Dubot, Coraline, Leary, Alexandra, Malaurie, Emmanuelle, You, Benoit

“…MicroRNAs (miRNAs) are promising biomarkers in ovarian cancer. Their kinetics during treatment might be useful for monitoring disease burden, and guiding…”
Get full text

Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial by Ray-Coquard, Isabelle, Harter, Philipp, Lorusso, Domenica, Dalban, Cécile, Vergote, Ignace, Fujiwara, Keiichi, Gladieff, Laurence, Lück, Hans-Joachim, Floquet, Anne, Chevalier-Place, Annick, Schnelzer, Andreas, Pignata, Sandro, Selle, Frédéric, Sehouli, Jalid, Brocard, Fabien, Mangili, Giorgia, Pautier, Patricia, De Giorgi, Ugo, Provansal, Magali, Heudel, Pierre-Etienne

“…To our knowledge, this is the first randomized trial in sex cord-stromal tumors, and it establishes weekly paclitaxel as standard-of-care therapy after…”
Get more information

What is new in the surgical treatment of pelvic gynecologic cancers? by Narducci, Fabrice, Sabban, Frédéric, Vanlerenberghe, Edith, Lesoin, Anne, Chevalier, Annick, Gauthier, Hélène, Taieb, Sophie, Castelain, Bernard, Leblanc, Eric

“…General tendency of modern cancerology is the research of adequacy between extent of disease and treatments. This concept is of course valid for gynaecology…”
Get more information

Surgical staging of early invasive epithelial ovarian tumors by Leblanc, Eric, Querleu, Denis, Narducci, Fabrice, Chauvet, Marie-Pierre, Chevalier, Annick, Lesoin, Anne, Vennin, Philippe, Taieb, Sophie

“…Early stage epithelial ovarian carcinoma is defined pathologically as a tumor strictly limited to one or both ovaries without any extra‐ovarian disease (i.e.,…”
Get full text

MR imaging of endometrial carcinoma: role and limits by Taïeb, Sophie, Ceugnart, Luc, Leblanc, Eric, Chevalier, Annick, Cabaret, Véronique, Querleu, Denis

“…To assess the MR imaging (MRI) in initial decision making of endometrial carcinoma. From january 1997 to march 2002, 86 patients with clinical stage I…”
Get full text

Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas by Penel, Nicolas, Depadt, Gérard, Vilain, Marie-Odile, Vanseymortier, Luc, Ceugnart, Luc, Taieb, Sophie, Mirabel, Xavier, Deligny, Nathalie, Chevalier, Annick, Baranzelli, Marie-Christine, Pichon, Fabienne, Hoguet, Dominique, Robin, Yves-Marie, Lartigau, Eric

“…Little is known about epidemiology of adults soft tissue and visceral sarcomas (ASTS). The frequency of previous cancers and associated genetic diseases has…”
Get full text

Actualités chirurgicales dans les cancers gynécologiques pelviens by NARDUCCI, Fabrice, SABBAN, Frédéric, VANLERENBERGHE, Edith, LESOIN, Anne, CHEVALIER, Annick, GAUTHIER, Hélène, TAIEB, Sophie, CASTELAIN, Bernard, LEBLANC, Eric

Get full text

IRM des cancers de l'endomètre : apports et limites by TAIEB, Sophie, CEUGNART, Luc, LEBLANC, Uric, CHEVALIER, Annick, CABARET, Véronique, QUERLEU, Denis

Get full text